feed,title,long_url,short_url
Motley,"Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?",https://www.fool.com/investing/2024/09/19/down-21-this-year-is-crispr-therapeutics-still-buy/?source=iedfolrf0000001,https://da.gd/1AzRt
